Annual flu jab may pose greater risk for lung cancer patients under immunotherapy
Geneva, Switzerland, April 26, 2017 - Lung cancer patients treated with PD-1/PD-L1 checkpoint inhibitors may be at increased risk of adverse events after receiving the...









